Flagship Harbor Advisors, LLC Bio Techne Corp Transaction History

Flagship Harbor Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$246.9 - $321.87 $73,082 - $95,273	-296 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$232.22 - $282.96 $54,803 - $66,778	236 Added 393.33%	296 $73,000
Q1 2020 May 12, 2020	SELL	$161.17 - $221.51 $16,116 - $22,151	-100 Reduced 62.5%	60 $11,000
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $18,019 - $21,098	-95 Reduced 37.25%	160 $35,000
Q3 2019 Oct 22, 2019	BUY	$183.56 - $216.72 $22,945 - $27,090	125 Added 96.15%	255 $49,000
Q2 2019 Jul 22, 2019	BUY	$188.72 - $215.43 $24,533 - $28,005	130 New	130 $27,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.